Hypersensitivity reactions associated with fidaxomicin use.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 24178248.
- Also identified by DOI 10.1093/cid/cit719.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report hypersensitivity reactions associated with fidaxomicin, an antibacterial drug approved for the treatment of Clostridium difficile-associated diarrhea. These reactions are viewed as significant because of severity and unexpected because fidaxomicin is minimally absorbed. The fidaxomicin labeling was revised to include information about the possibility of hypersensitivity reactions.
Medical subject headings
- Aminoglycosides
- Anti-Bacterial Agents
- Drug Hypersensitivity